All posts by imreal

Dental Care Alliance Named Best Place to Work for Diversity


“Being named one of America’s Greatest Workplaces for Diversity is a tremendous honor for DCA,” shared Jerry Rhodes, DCA’s Chief Executive Officer

Dental Care Alliance (DCA) is exceptionally proud to announce that it has been named one of America’s Greatest Workplaces for Diversity 2023 by Newsweek.

Newsweek, in cooperation with Plant-A Insights Group, conducted an independent study to determine Americas Greatest Workplaces for Diversity for 2023. The list was determined by conducting a large-scale independent survey with 350,000 completed company reviews by employees who work for companies employing at least 1,000 employees in the U.S. The study was 100% independent, as no employers were informed about the study.

As one of only two dental support organizations (DSOs) honored with this designation, DCA consistently prioritizes diversity, equity, and inclusion (DEI) across the organization. Under the leadership of James Nick, Chief Revenue Officer, DCA launched its DEI Council in early 2020 – thoughtfully established on the organization’s 32-year foundation of supporting compassionate, empathetic care to patients and its U-SMILE values. The Council comprises diverse team members across the organization, including allied doctors, hygienists, and office and support staff.

“Through emphasis on communication and education, talent development, and talent attraction, and giving back to the community, the DCA’s DEI Council seeks to promote and encourage diversity within all levels of the company so that we are better suited to drive change and organizational growth,” shared Erika Williams, Chief Talent Officer, and Chair of the Council.

DCA champions every kind of diversity—diversity of backgrounds, of thought, and of race, age, and gender. Through these efforts, DCA is better prepared to evolve and grow stronger as new opportunities emerge. The team is focused, from day one, on making current and future team members feel welcomed and open to sharing their thoughts, beliefs, and experiences for the betterment of the company, supported practices, and communities.

Before being honored as part of this prestigious group of businesses focused on diversity, most recent employee engagement surveys (2021-2022) indicated that DCA’s team members rated the company’s valuation of diversity highest among all questions.

DCA believes in the importance of creating an organization that welcomes everyone who walks through its doors. They are a diverse and talented team, making a true and lasting difference in the lives of others. The patients they serve, who are equally as diverse as are DCA’s team members, look to the leading DSO and its allied practices for confidence, compassion, and care.

“Being named one of America’s Greatest Workplaces for Diversity is a tremendous honor for DCA,” shared Jerry Rhodes, Chief Executive Officer. “We strive to promote diversity, equity, and inclusion, and believe that an organization that reflects those values better represents the patients and communities that DCA’s allied practices serve.”

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports more than 390 uniquely branded practices with more than 900 dentists across 22 states. DCA’s allied practices represent all dental specialties and treat patients under more than 140 brand names. https://www.dentalcarealliance.com

Share article on social media or email:

Prevent Blindness Provides Free Resources for February’s Age-related Macular Degeneration (AMD) and Low Vision Awareness Month


Prevent Blindness offers free educational materials for February’s Age-related Macular Degeneration and Low Vision Awareness Month.

“As our population ages, the number of people who are affected by vision loss will continue to climb,” said Jeff Todd, president and CEO of Prevent Blindness.

As part of February’s Age-related Macular Degeneration (AMD) and Low Vision Awareness Month, Prevent Blindness, the nation’s leading eye health and safety nonprofit organization, is offering free resources to the public to help educate and empower individuals, and their care partners, to make informed decisions about their vision and eye health.

AMD is an eye disease that is a leading cause of vision loss for Americans ages 50 and older. It affects central vision, where sharpest vision occurs, causing difficulty conducting daily tasks such as driving, reading, and recognizing faces. According to a new study leveraging the Centers for Disease Control and Prevention’s (CDC) Vision and Eye Health Surveillance System, “The Prevalence of Age-Related Macular Degeneration in the United States In 2019,” more than 19 million Americans ages 40 and older were estimated to be living with AMD in 2019. Prevalence of AMD increases with age. Among persons ages 80 and older, approximately 3 in 10 have early AMD, and approximately 1 in 10 have the vision-threatening late form.

The Prevent Blindness “AMD Learning Center” at PreventBlindness.org/AMD, and the free GuideMe app, are designed for those who have been recently diagnosed with AMD. GuideMe works by asking a few questions about the user and the user’s AMD diagnosis. It then creates a customized guide with helpful information, tips, resources and suggested steps to take to be proactive about protecting vision. AMD fact sheets and shareable graphics in English and Spanish are also available for free download.

Geographic Atrophy (GA) is the advanced form of dry AMD. Prevent Blindness offers resources in English and Spanish, including a downloadable fact sheet, a series of shareable social media graphics and a dedicated webpage. Prevent Blindness developed the content of these resources with funding provided by Apellis Pharmaceuticals, Inc.

Prevent Blindness recently launched the redesigned resource, “Living Well With Low Vision.” One of the most visited web resources from Prevent Blindness, the program provides accessible guides, such as the “Self-Help Guide to Non-Visual Skills” and “The ABC’s of Caring for the Visually Impaired” handbook. Additionally, the site has patient and care partner resource directories, and a new feature dedicated to vision loss and mental wellness. Visitors can also find information on the latest vision research, disease-specific news and clinical trials. This resource is supported by grants from Genentech and Horizon Therapeutics.

“As our population ages, the number of people who are affected by vision loss will continue to climb,” said Jeff Todd, president and CEO of Prevent Blindness. “Thanks to our generous partners, we are able to provide the public with information they need to hopefully help slow the progression of AMD, as well as the resources for patients and care partners to face the many challenges that low vision can present.”

For more information on AMD, please visit PreventBlindness.org/AMD. For information on geographic atrophy, please visit PreventBlindness.org/geographic-atrophy.

And, for more information on Living Well With Low Vision, or other general eye health information, please visit lowvision.PreventBlindness.org/.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

DecisionHealth’s 2023 Home Health Administrator’s Summit will equip home care industry leaders to innovate, diversify, and grow their agencies in the year ahead


News Image

DecisionHealth is one of the most trusted voices in Post-Acute Care and their conferences offer a great opportunity to learn and network with some of the brightest minds in the business.

DecisionHealth’s Home Health Administrator’s Summit is the place for home care industry leaders and agency heads to innovate, strategize, diversify, and grow their agency. From May 8–10, 2023, at Caesars Palace in Las Vegas, top industry experts will gather to share sales and marketing best practices, success stories, and take-home tools to help home health agencies cut costs and ultimately improve their bottom line.

The summit kicks off on May 8, 2023, with a preconference focused on recruitment and retention where attendees can learn the best practices to hire, engage, and keep the best talent.

The main conference provides attendees with additional education and networking opportunities with many of the nation’s most well-known home health thought leaders, helping agencies to create a plan of action for the future.

When asked what expert speaker Beau Sorensen, director of finance and operations at First Choice Home Health and Hospice, was looking forward to most, he said, “DecisionHealth is one of the most trusted voices in Post-Acute Care and their conferences offer a great opportunity to learn and network with some of the brightest minds in the business. I am looking forward to presenting and can’t wait to see what innovative ideas are showcased at this year’s Administrator’s Summit!”

Attendees will walk away with strategies to leverage opportunities and combat challenges facing the home health industry, including how to:


  • Gain a full picture of the current and future regulatory environment.
  • Win Medicare Advantage business.
  • Achieve lower-than-average turnover rates by recruiting and retaining top clinical talent.
  • Improve outcome scores to secure HHVBP bonuses.
  • Leverage telehealth opportunities and technology for improved quality, savings, and compliance.
  • Avoid auditor scrutiny related to incomplete documentation.
  • Navigate the home health employment legal and regulatory landscape.
  • And more!

For more information, visit https://www.decisionhealth.com/HHA2023.

If you have questions or would like additional information, please contact a Customer Service representative at 1-855-225-5341, or e-mail HCEvents@hcpro.com.

###

About DecisionHealth

DecisionHealth, an HCPro brand, is the industry’s leading source for home health agencies and medical practice facilities to receive the latest news, analysis, and regulatory guidance on Medicare coding and reimbursement, benchmarks, payments, and HIPAA compliance through its flagship publications, as well as a wide selection of coding books, educational events, and online tools. Visit http://www.decisionhealth.com.

About HCPro

For over 34 years, HCPro, a division of Simplify Compliance LLC, has specialized in providing the latest healthcare regulatory information through industry-leading publications, continuing education, online coding platforms, instructor-led training, events, consulting services, and more to deliver consistent training, achieve compliance, and maximize workflow efficiencies, resulting in measurable performance and financial improvements. Visit http://www.hcpro.com/.

Share article on social media or email:

Convey911 Closes Seed Funding Round, Rapidly Scales Multilingual Communications Platform to Address Language Translation Gaps in Public Safety Over Text, Video, and Voice


News Image

Today, Convey911, a Baltimore-based multilingual technology company serving public safety and local government, announced it has closed a seed funding round and added critical new features to its patent-protected communications and language translation platform.

Convey911 is an easy to use, add-on technology that enhances existing public safety communications infrastructure. It serves as a framework between call handling, computer-aided dispatch, and field-based devices that address language translation and workflow challenges and helps agencies meet FCC Enhanced 911(E911) indoor location accuracy rules and Next Generation 911 standards.

With customers in multiple states, Convey911 offers seamless real-time, bi-directional language translation in 350+ languages for voice and text-to-911 calls, text-from-911, 311, and 988. In addition, Convey911 adds text with translation capabilities to existing landlines, offers embedded translation through its video and voice services, and is the leading provider of real floor-level Z-Axis (height above terrain).

Convey911 was founded by Co-Founders Jeffrey Bruns and Lisa Reagan who, together with their team, have deep experience working in public safety and serving customers nationwide. The financing round is being led by Founder Works, the investment vehicle for Alex Ford, the founder of Praetorian Digital and former CEO of Lexipol as well as creator of Police1.com and FireRescue1.com. The round allows Convey911 to accelerate go to market, scale its platform, and hire key employees.

“Lack of real-time access to interpreters for all languages, including Spanish, continues to be a problem for all verticals in the public safety sector. Long wait times and clunky workflows leave departments at risk. Convey911 is providing a full suite of communications and real-time translation tools built to meet the security and evidentiary requirements of public safety and law enforcement. Convey911 uses artificial intelligence (AI) and machine learning, as well as provides a point and click workflow for accessing certified human translators. Ultimately our goal is to decrease risk and command staff liability while also increasing officer safety,” said Lisa Reagan, CRO and Co-Founder, Convey911.

Convey911 was built with law enforcement needs in mind. All communications are cryptographically signed and stored securely in the AWS GovCloud, meeting HIPAA, CJIS and other compliance regulations required by government and law enforcement agencies. Convey911 is a standalone system or may be used inside RapidSOS. In addition, the Convey911 platform includes one-click-enablement workflows so users can easily choose between text, voice or video communications, or access a network of over 22,000 certified human interpreters.

“Simplifying and improving communication is at the core of Convey911,” said Jeff Bruns, CEO and Co-Founder, Convey911. “We’ve built a cloud-native integration platform because we believe helping public safety meet their mandates should be simple for them. Also, our capabilities are as valuable in other sectors as they are in public safety. This round of funding will allow us to scale rapidly to address language and communication needs both within public safety and beyond.”

About Convey911

Convey911 is a communications and language translation platform for 911, Fire & EMS, law enforcement, local government, and enterprise solutions. Convey911 is a first mover in developing technology to provide voice, video and text translation and provide an over-the-top solution for text-to-911 language translation. Convey911’s clients include public safety departments and government agencies across North America. Convey911 is headquartered in Baltimore, MD. Learn more at Convey911.com.

About Founder Works LLC

Founder Works empowers software as a service (SaaS) and digital content entrepreneurs to rapidly scale their businesses and accelerate their entrepreneurial journey. Led by Alex Ford, the founder of Praetorian Digital and former CEO of Lexipol as well as creator of Police1.com, FireRescue1.com and EMS1.com, it provides capital and expertise to early-stage companies that serve b2b verticals not well suited to traditional venture capital but too early for private equity. Learn more at FounderWorks.com.

Share article on social media or email:

Andrew Demetre, Charleston Fitness Coach, Explains Training Strategy in New Interview


Andrew Demetre a Charleston fitness coach, is excited to announce that he is featured in a new interview with IdeaMensch. In the interview, Demetre describes how he got into fitness, created his business, his unique approach to business, and more.

In the interview, Demetre explains that he moved to Charleston, South Carolina, during the COVID-19 pandemic. Realizing that he was just “wasting away in quarantine,” he quickly learned just how valuable it was to increase the versatility of training programs.

Without access to a gym, Andrew Demetre incorporated calisthenics into his regimen, which didn’t require any weights. After finding success in his own workouts, he was then able to expand his client base to make Zoom calls and house calls before building an at-home gym in his garage.

During this journey, Andrew Demetre, realized that following the “traditional” training model wasn’t necessary anymore. Not only did he find that most of his clients preferred working from home, but they also preferred working out from home.

As he explains in the IdeaMensch interview, all his clients today are bodybuilders with very busy lives. As such, they don’t fit into the traditional definition of someone who lifts weights.

“I’ve spent most of my career in gyms,” said Andrew Demetre in the interview. “I never thought about the possibility of being able to make the same gains at home without even needing weights. That doesn’t mean I don’t incorporate weight training, but I want my clients to know there’s more flexibility than they realize.”

In addition to talking about his journey in fitness, Andrew Demetre explains what his typical day looks like and how he ensures it’s productive, how he brings ideas to life, the trends that excite him, and the habits that make him more productive as an entrepreneur.

IdeaMensch is an interview platform for doers, makers, and entrepreneurs, helping them expand their reach through the publication of their in-depth interview pieces.

In his interview, Demetre, says that word-of-mouth recommendations and marketing are the strategies that helped him to grow his business. He said that building good rapport among clients is important because they’ll often tell others about his business.

This is especially important in the world of fitness, he explains, as he knows his clients won’t be training forever. When they stop working with him, they’ll still bring tons of value to Andrew Demetre’s business by telling others about him.

To read the full interview with Andrew Demetre, Charleston fitness coach, visit https://ideamensch.com/andrew-demetre-charleston.

About Andrew Demetre

Andrew Demetre, Charleston health coach, physical trainer, and bodybuilder, who first found his calling during the pandemic when he realized that many of his clients preferred working out from home. These days, Demetre uses his expertise to train clients from home, whether in the greater Charleston area or worldwide. Andrew firmly believes every client can achieve their ideal body through hard work and dedication — no gym membership needed.

Share article on social media or email:

METAvivor Announces Metastatic Breast Cancer Research Awards


METAvivor Research and Support announces 27 new grant awards for metastatic breast cancer research totaling $5.75 million.

Metavivor Research and Support Inc., a non-profit organization dedicated to funding research for stage IV metastatic breast cancer (MBC), announces 27 grant awards totaling $5,750,000. The research grants will enhance the understanding of metastatic breast cancer, help improve current treatments and develop greatly needed therapeutic options to combat the complicated disease. Since its founding in 2009, METAvivor has put 100% of donations into its peer-reviewed research grant program.

Metastatic breast cancer (also known as stage IV or advanced stage cancer) is the spread of breast cancer to other parts of the body — most commonly to the bones, liver, lungs and/or brain. Approximately 30% of early-stage breast cancer patients metastasize, with the mean survival after diagnosis being 33 months. In the U.S., only 2-5% of all cancer research funds are dedicated to metastatic breast cancer research – yet 98% of all breast cancer deaths are caused by a metastasis.

“METAvivor is thrilled that we are able to continue to fund peer-reviewed research specifically for metastatic breast cancer. The research grants hold promise for future treatments and therapies that will one day, change metastatic breast cancer from a terminal disease to one that is survivable and manageable with a good quality of life,” said Jamil Rivers, president of METAvivor.

Metavivor is awarded grants for the 2022 research cycle in three award categories: The Early Career Investigator Award program is focused on funding grants for early career metastatic breast cancer researchers, The Translational Research Grant and Advisor’s awards program are targeted at career metastasis researchers with total awards of up to $250,000 per grant.

The 27 grants that METAvivor is funding in this grant cycle, bring the grand total of metastatic breast cancer-specific research awards to $28,900,000.00. “We are truly thankful to our donors who continue to keep metastatic breast cancer research at the forefront of their giving,” said Rivers.

METAvivor’s Metastatic Breast Cancer Early Career Research Grant Awards

Corinne Beinat,PhD, BSc (Hons), Stanford University School of Medicine – A Theranostic Strategy for Precision Imaging and Treatment of Metastatic Triple-Negative Breast cancer – Presented in loving memory of Be Bold and Behold honorees Kathryn Petrides and Lisa M. Laudico

Jennifer Caswell-Jin, MD, Stanford University School of Medicine – Fibroblast growth factor receptor signaling and immune composition in estrogen receptor-positive metastatic breast cancer – Presented by the Linda (LeClair) Sousa, A Better Dream Foundation In memory of Linda (LeClair) Sousa

Amanda Clark, PhD, University of Pittsburgh – Extracellular vesicles regulate metastatic breast cancer dormancy in the liver – Presented by Northwest Arkansas Metsquerade, Runway for Research

Ana Gomes, PhD, H. Lee Moffitt Cancer Center & Research Institute – Metabolic vulnerabilities of dormant disseminated breast cancer cells – Presented in memory of Molly B. Taylor

Quanyin HU, PhD, School of Pharmacy, University of Wisconsin-Madison – Targeted degradation of BET proteins in combination with immune checkpoint inhibitors for treating metastatic triple-negative breast cancer – Presented In memory of Andi Myers and Elizabeth Seagraves Murray and those from the support group “Living with MBC in DENJPA” that passed away in 2022

Ines Velazquez-Quesada, PhD, Temple University, College of Engineering, Bioengineering Department Impact of the neuron-breast cancer cell interactions on the growth and survival of brain metastasis – Presented in memory of Tonyia Lucas and her Hope To Find A Cure

METAvivor’s Metastatic Breast Cancer Advisors Research Award

Stuart S. Martin, PhD, University of Maryland, Baltimore – Leveraging combined ctDNA and CTC analysis to optimize treatment for existing bone metastases – Presented in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Danny Welch, PhD, University of Kansas Medical Center Research Institute – Mitochondrial Modifiers of Metastasis – Presented by The Pittsburgh Metsquerade in honor of members who died of MBC during event planning: Jill Griffin, Andrea Dimond, Lori Czyzewski and Sophia Holland

METAvivor Metastatic Breast Cancer Translational Research Awards

Khalid Sossey-Alaoui, PhD, Case Western Reserve University and MetroHealth Medical Center – Role of YB1 in Triple Negative Breast Cancer Metastasis

Prasanna Alluri, MD, PhD, The University of Texas Southwestern Medical Center at Dallas – Targeting CDK4/6 inhibitor resistance in patients with metastatic, ER-positive breast cancer – Presented by #LightUpMBC Ambassador team in memory of Jessica Moore

Andrei Bakin, PhD, Roswell Park Comprehensive Cancer Center – Development of Novel Immune Therapy Approaches for Metastatic Breast Cancer – Presented by #LightUpMBC Ambassador team in memory of Rosylin Weston

Elvin Blanco, PhD, Houston Methodist Research Institute – Mitochondrial biogenesis for T-cell priming and enhanced immunotherapy in metastatic breast cancer – Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Katherine Cook, PhD, Wake Forest University School of Medicine – Improving ER+ bone metastatic breast cancer outcomes through metabolic re-programming of the microenvironment – Presented by Lake Norman Metsquerade in honor of Hilary Blake Hamilton

Gokul Das, PhD, Roswell Park Comprehensive Cancer Center, Repurposing Tamoxifen to Treat Molecularly Stratified Metastatic Triple Negative Breast Cancer – Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Bisrat Debeb, DVM, PhD, The University of Texas MD Anderson Cancer Center -Targeting sEcad – PDI axis for the treatment of breast cancer brain metastasis    

Ayesha Shajahan-Haq, PhD, Georgetown University – Application of a novel ruthenium-based anticancer therapy in ER+ metastatic breast cancer – Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Jonathan Kessler, MD, City of Hope / Beckman Research Institute -Combination of Immune Checkpoint Inhibitor and Hepatic Radioembolization for the Treatment of Liver-Dominant Metastatic Breast Cancer – Presented by Minneapolis Metsquerade in memory of Toniya Lucas and Rachael Masters

Laurie Littlepage, PhD, University of Notre Dame – Targeting Endocrine Therapy Resistance in Bone Metastasis

Hui-Wen LO, PhD, McGovern Medical School at The University of Texas Health Science Center at Houston – Targeting Breast Cancer Brain Metastases by an FDA-Approved Antifungal Drug and its Novel Analog – Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Lluis Morey, PhD, Sylvester Comprehensive Cancer Center, University of Miami – Dual targeting of an epigenetic machinery and a cellular receptor to block metastatic breast cancer – Presented by The Pittsburgh Metsquerade in honor of members who died of MBC during event planning: Amy Fletcher, Bindy Koontz, Roberta Thomas Szpara and Laura Williams

Jitesh Pratap, PhD, Rush University – Targeting microtubule dynamics and endosomal trafficking for bone metastasis of breast cancer – Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Axel Schönthal, PhD, University of Southern California – Controlled Opening of the Blood-Brain Barrier to Enable Effective Therapeutic Access to Breast Cancer Brain Metastases – Presented in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Andrew D. Seidman, MD, Memorial Sloan Kettering Cancer Center – Untangling the role of the brain metastasis microenvironment in HER2 positive breast cancer brain metastases to inform rational systemic treatment strategies – Presented by Cycle4Helen in honor of Helen O’Leary

Ghada Sharif, PhD, Lombardi Comprehensive Cancer Center – Targeting Occult Cancer Cell Subpopulations Driving Metastases Growth – Presented by Color Street Foundation

Theresa Vincent, PhD, New York University Grossman School of Medicine – Targeting breast cancer brain metastasis using a brain penetrable RNA Polymerase I inhibitor – Presented by The Met Gala Santa Clarita in gonor of Eva Miranda Crawford and Amy Steffe Lohmann

Min Yu, PhD, The University of Maryland School of Medicine, Baltimore – Targeting IGFBP3 signaling as a novel therapy for ESR1-Y537S mutant driven bone metastasis – Presented in honor of Tara Kuipers – Creator of #LightUpMBC Color Fun Run

Lin Zhang, PhD, The University of Texas MD Anderson Cancer Center – Altering the Metabolic Tumor Microenvironment to Impede Breast Cancer Brain Metastasis – Presented in honor of Ashleigh Griffin

ABOUT METAVIVOR

METAvivor Research and Support Inc. is an Annapolis-based, volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients in 2009. The organization’s main focus is to fund critical research that will lead to advances in treatment options, quality of life and survival for patients diagnosed with MBC. Since 2009, METAvivor has awarded 193 research grants totaling $28,900,000. METAvivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.

METAvivor also raises awareness of MBC, provides support for people living with this disease, and offers opportunities for others to help make a difference for the metastatic community. METAvivor has gained a rapidly growing following within the breast cancer community and has become a leader the metastatic breast cancer community.

Visit us at http://www.metavivor.org and follow us on Facebook, Twitter and Instagram.



Greenlight Guru Releases 2023 MedTech Industry Benchmark Report


https://www.greenlight.guru/

Built on survey data gathered from over 600 medical device professionals, the study provides a comprehensive and in-depth view into new trends, outlooks, challenges, and opportunities in the MedTech market.

Greenlight Guru, the leading cloud-based platform purpose-built for MedTech companies, announced the release of its 2023 MedTech Industry Benchmark Report. Built on survey data gathered from over 600 medical device professionals, the study provides a comprehensive and in-depth view into new trends, outlooks, challenges, and opportunities in the MedTech market. You can download the report for free here.

As economic headwinds continue across nearly every major market, the medical device industry has not been immune to the financial slowdown. Fewer than 26% of medical device companies say they expect strong economic gains in the coming year; dealmaking and funding rounds were also down, with investors exercising more caution in the mergers and acquisitions market. Now, with fewer companies prioritizing bringing new products to market, uncovering industry trends and shifts in data-driven reports like Greenlight Guru’s are more essential than ever.

“We set out to survey as many medical device professionals as possible. Diversifying our sample size makes our data more accurate, relevant, and helps us better tell the shared story of the industry,” says product marketing specialist Radhika Pandya.

The report demonstrates how actions to improve efficiency and enhance quality, such as employee training and updating legacy quality management systems can be a huge boon for innovation and steadiness in 2023.

“There’s a tremendous amount of value in this report for our customers as well as the industry at-large. For instance, last year’s report was all about innovation and rapid growth, whereas now it’s about tightening the reins and ensuring compliance,” says Chief Marketing Officer Jeff Perkins. “Year-over-year, that’s a very significant change, and the data really gives you a gut-check as to where your medical device company stands within the rest of the market.”

The release of the 2023 MedTech Industry Benchmark Report was part of Greenlight Guru’s 2023 State of Medical Device True Quality Summit Series, giving thousands of attendees a glimpse into the strategies, tactics, and technologies used today to streamline product development, ensure compliance, and promote quality. You can watch the sessions from the True Quality Summit here.

About Greenlight Guru

Greenlight Guru is the leading cloud-based platform purpose-built for MedTech companies. The end-to-end solution streamlines product development, quality management, and clinical data management by integrating cross-functional teams, processes, and data throughout the entire product lifecycle. Greenlight Guru’s platform is used by organizations across the globe that are replacing their disjointed, legacy tools and solutions to bring life-changing products to people faster, and with less risk. For more information, visit http://www.greenlight.guru.

Media Contact

PR at Greenlight Guru

pr@greenlight.guru

Share article on social media or email:

Apex Trials Joins hyperCORE International’s Clinical Trial Network


Apex Trials

“Entrance into the prestigious hyperCORE site solutions family, one of the industry’s best, is a validation and affirmation of this strategic focus. We are thrilled to join hyperCORE,” said William Rowe, President and CEO of Nutrasource.

hyperCORE International is kicking off 2023 in an exciting manner by welcoming Apex Trials to its super network of clinical trial sites. This new addition to their family of alliance partners allows the organization to continue expanding their reach and capabilities across the clinical research arena.

Headquartered in a state-of-the-art, 17,000 square foot facility in Southwestern Ontario, Canada, the newly named Apex Trials is a premium clinical trial site, conducting studies in both the pharmaceutical and nutraceutical industries. Under the leadership of Primary Investigator Dr. Anthony Bier, their primary areas of clinical trial focus are Phase I / Pharmacokinetic studies through Phase IV Studies for both Pharmaceutical and Nutraceuticals for cardiovascular disease, hypertension, dyslipidemia, diabetes, irritable bowel syndrome, and weight management.

“The Apex Trials team at Nutrasource has been working diligently to prepare and scale our site for pharmaceutical studies. Entrance into the prestigious hyperCORE site solutions family, one of the industry’s best, is a validation and affirmation of this strategic focus. We are thrilled to join hyperCORE,” said William Rowe, President and CEO of Nutrasource.

Apex Trials is part of global CRO and leading nutraceutical nutraceutical and pharmaceutical life sciences company Nutrasource. Nutrasource brings together the strategy, expertise and services required to help clients commercialize health and wellness products with strong science and regulatory confidence. Their unique offering of clinical trial management full suite clinical trial services, strategic and global regulatory consulting services, along with a state-of-the-art clinical trial site has been developed with one goal in mind – success in the global marketplace.

The partnership with Apex Clinical Trials brings hyperCORE new and expanded capabilities in health product development ranging from dietary supplements, medical foods and devices, biologics, and other pharmaceuticals. This greatly adds to hyperCORE’s vast array of services and further strengthens its position as a premier provider of clinical trial services.

“It’s been a pleasure to work with Apex Trials over the years, and even more exciting that they are joining hyperCORE. This will help strengthen hyperCORE’s Canadian approach on pivotal clinical trials and bring expertise on nutraceutical clinical research,” said Mark Lacy, Founder and CEO of Benchmark Research and Chair of hyperCORE’s exective board.

At the current time, hyperCORE International is comprised of over 100 clinical trial sites across North and South America and offers streamlined efficiencies such as single budget and contracts, and shared platforms for rapid scalability; the network also offers unparalleled access to diverse populations and depth of expertise across vaccine, metabolic disorders, dermatology, and many additional therapeutic areas.

About hyperCORE International:

Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. It is an industry leader, providing Phase I-IV clinical trial services with more than 100 active research sites on two continents and five countries. Its member companies have more than 100 years of combined experience and completed more than 7,000 studies helping to evaluate thousands of new drugs and treatments in more than 140,000 randomized patients. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.

hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, diversity in enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.

Learn more at hypercoreinternational.com.

Share article on social media or email:

Olive Fertility Centre Recognized as #1 Canadian Clinic for Superior Outcomes in Egg Freezing


At Olive, we have always known that our incredible laboratory team is second to none. We are thrilled to be recognized by DEB USA, one of the largest egg banks in the world, for our outstanding outcomes, the excellence of our lab and egg thawing protocol.

Olive Fertility Centre is delighted to announce that the Olive Fertility lab has received multiple awards, including top Canadian Clinic for Superior Outcomes in Egg Vitrification Warming 2022 and Masters of ART at this year’s LOVE Awards by Donor Egg Bank USA.

According to Donor Egg Bank USA (DEB USA) these honours are awarded only to clinics and individuals with the ability to consistently provide high levels of innovation, performance, and inspiration in the field of assisted reproductive technology. The Excellence Awards were designed to recognize superior embryologists who have mastered the highly technical skill of vitrification freezing and warming.

“At Olive, we have always known that our incredible laboratory team is second to none. We are thrilled to be recognized by DEB USA, one of the largest egg banks in the world, for our outstanding outcomes, the excellence of our lab and egg thawing protocol,” says Dr Gary Nakhuda, Co-director Olive Fertility Centre. “These prestigious awards are a testimony to the quality of our lab and the skill of our highly trained team of embryologists and andrologists. We have devoted an extreme level of attention to detail to every aspect of the design of the lab to create the best possible environment to ensure excellent outcomes and patient safety. But beyond our technology what really sets us apart is the outstanding group of scientists that run our lab.”

At the lead is Dr Salah Abdelgadir, PhD, who has been a laboratory director for nearly 20 years, with certification as a Technical Supervisor (TS) and High Complexity Lab Director (HCLD) from the American Board of Bioanalysis. He is the only PhD-educated lab director in British Columbia who works on-site, full-time to maintain strict and direct supervision of all laboratory processes and procedures. Working with Dr Abdelgadir is an entire team of some of the best embryologists and andrologists in the field.

“Our world-class lab is why Olive has among the highest pregnancy rates in Canada and is part of our commitment to provide families with the best chance of having a healthy baby,” says Dr Abdelgadir.

After careful evaluation of 28 partner practices and over 150 reproductive specialists in the U.S., Canada and Puerto Rico, Donor Egg Bank USA selected recipients for awards in Fertility Practice Excellence in a number of categories. Candidates were evaluated based upon clinical pregnancy rates achieved per egg lot thawed and overall practice excellence.

Olive Fertility Centre, with clinics in Vancouver, Surrey, Kelowna, and Victoria, offers a state-of-the-art IVF lab, personal care teams and innovative programs that include specialized genetic testing, egg freezing, and prenatal NIPT testing.

Share article on social media or email:

2022 Holiday eCommerce Shopping Exceeded Expectations — So Will Chargebacks


News Image

When businesses stretch their marketing budget or payment options too far during the holiday season, they fail to allocate any spending toward the annual spike in chargebacks merchants face in the first quarter of the year — many of which may be fraudulent.

As holiday shoppers navigated the post-COVID-19 inflationary environment in 2022, global online sales topped $1.14 trillion, according to a report from Salesforce.(1) Additionally, new alternative payment methods have fueled online and card-not-present transactions. While eCommerce businesses gained a bigger share of the holiday season spending, transaction experts warn merchants that an increase in online purchases and alternative methods of payment will likely include a correlated rise in chargebacks to start 2023.

Chargebacks occur when customers call their bank to refute a charge, and the bank provides them with an instant refund, which they take from the merchant’s account. While chargebacks are a necessary failsafe to protect cardholders against fraudulent activity, statistics show that illegitimate chargeback claims have skyrocketed since 2020, leading to millions in unnecessarily lost revenue.

With fraudulent chargeback claims, or first-party fraud, accounting for as much as 70% of all credit card fraud,(2) Monica Eaton, founder of Chargebacks911, warns merchants that some efforts to attract holiday shoppers may lead to an increase in chargebacks 30 to 60 days after a transaction.

“With the surge in retail shopping exceeding market predictions this past holiday season by approximately $60 billion, it’s important that merchants are prepared for the wave of chargebacks that impact retailers this time of year,” says Eaton. “When businesses stretch their marketing budget or payment options too far during the holiday season, they fail to allocate any spending toward the annual spike in chargebacks merchants face in the first quarter of the year — many of which may be fraudulent.”

Total merchant losses from chargeback fraud are set to exceed $206 billion for Mastercard alone between 2021 and 2025.(3)

New payment methods

Chargebacks are the fastest-growing problem for online merchants. The adoption of new payment methods, including credit cards, prepaid cards, cryptocurrency, and Buy Now, Pay Later (BNPL), have accelerated the incidences of first-party fraud, with an estimated 35% increase in chargeback fraud since the start of the pandemic.(4)

“Consumers are using newer payment methods like value-added cards, digital coins, and BNPL,” says Eaton. “Unfortunately, there hasn’t been enough education for eCommerce merchants to understand the unintended consequences of these payment methods.”

For example, Eaton notes that while a chargeback filed for a BNPL transaction more often than not goes to the credit card provider and not the merchant, there may still be an increase in products being returned for a refund, as consumers are more likely to make impulsive purchases on products they don’t have to pay for upfront, but still can’t afford. According to Eaton, retailers should study each credit card provider’s merchant dispute policies before entering into an agreement.

Retail inventory gluts, combined with labor shortages, are another factor increasing chargebacks in 2023. As the supply-chain shortages from 2021 started to clear up last year, large retailers like Costco, Walmart, and Target saw 26% to 43% higher-than-expected inventory.(5)

“Retailers with stockpiled inventory offer big discounts — which means potentially massive sales volumes,” says Eaton. “We saw how labor shortages caused shipping delays, and in a lot of cases, people received their items after the holidays, leading them to file a chargeback for a purchase they feel they did not receive in time. While merchants aren’t responsible for labor shortages or delays caused by shipping entities, they bear all the financial consequences from unsatisfied customers.”

Protection

According to Eaton, there are risk-management strategies that eCommerce and other retail merchants can use to protect themselves from the steep rise of chargebacks facing them in the first few months of 2023. To sustainably protect transactions for both the buyer and seller requires merchants to utilize better technology, more data intelligence, and agile platforms for financial institutions and eCommerce sellers like the transaction dispute solutions Chargebacks911 offers.

Additionally, Eaton urges consumers to first dispute transactions with the store they made the purchase with rather than resort to filing a chargeback claim with their financial institution as their first step. Contacting the merchant first may resolve the dispute without unnecessary chargeback fees for the retailer, a cost that could ultimately be passed on to consumers through increased prices.

“Tackling the growing complexities and challenges of dispute management requires ongoing innovation,” says Eaton. “We are dedicated to powering chargeback management for global eCommerce businesses and financial institutions at the highest possible level.”

About Chargebacks911

Chargebacks911 is the global leader in chargeback prevention and remediation technology. As a provider or supplier to financial technology companies, Chargebacks911 safeguards more than 2.4 billion transactions per year on behalf of clients in 87 countries around the world. For details on Chargebacks911’s comprehensive dispute management solutions, visit https://chargebacks911.com

References: 

1. Conley, P. (2023, January 9). Online holiday season sales topped $1.14 trillion globally, Salesforce says. Digital Commerce 360. Retrieved January 27, 2023, from digitalcommerce360.com/2023/01/09/online-holiday-season-sales-topped-1-14-trillion-globally-salesforce-says/#:~:text=Global%20online%20sales%20during%20the,and%20December%2C%20according%20to%20Salesforce.

2. Ethoca. “What is Friendly Fraud?.” December 15, 2020, Ethoca,ethoca.com/blog/what-is-friendly-fraud

3. Davis, Sarah. “5 Signs You Could Benefit From Ecommerce Fraud Prevention This Holiday Season.” August 18, 2022, ROI Revolution,roirevolution.com/blog/2022-holiday-ecommerce-stats-trends-predictions/#:~:text=In%202022%2C%20US%20retail%20ecommerce,set%20to%20exceed%20%24206%20billion

4. Lourenco, Rafael. “3 new fraud risks that come with alternative payments.” Customer Experience Blog. July 7, 2021. blogs.oracle.com/cx/post/3-new-fraud-risks-with-alternative-payments

5. Souza, Kim. “The Supply Side: Retailers grapple with widespread inventory glut in recent quarter.” TB&P. June 26, 2022. talkbusiness.net/2022/06/the-supply-side-retailers-grapple-with-widespread-inventory-glut-in-recent-quarter/.